Jae-Hyuck Shim to Osteoporosis
This is a "connection" page, showing publications Jae-Hyuck Shim has written about Osteoporosis.
Connection Strength
2.603
-
Lin C, Yang YS, Ma H, Chen Z, Chen D, John AA, Xie J, Gao G, Shim JH. Engineering a targeted and safe bone anabolic gene therapy to treat osteoporosis in alveolar bone loss. Mol Ther. 2024 Sep 04; 32(9):3080-3100.
Score: 0.803
-
Oh WT, Yang YS, Xie J, Ma H, Kim JM, Park KH, Oh DS, Park-Min KH, Greenblatt MB, Gao G, Shim JH. WNT-modulating gene silencers as a gene therapy for osteoporosis, bone fracture, and critical-sized bone defects. Mol Ther. 2023 02 01; 31(2):435-453.
Score: 0.712
-
Yang YS, Xie J, Wang D, Kim JM, Tai PWL, Gravallese E, Gao G, Shim JH. Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis. Nat Commun. 2019 07 04; 10(1):2958.
Score: 0.568
-
Sarkar A, Sarkar S, Anwar A, Kim JW, Shim JH, John AA. The Growing Significance of microRNAs in Osteoporosis. Cells. 2025 Dec 01; 14(23).
Score: 0.222
-
Anwar A, Kaur T, Chaugule S, Yang YS, Mago A, Shim JH, John AA. Sensors in Bone: Technologies, Applications, and Future Directions. Sensors (Basel). 2024 Sep 24; 24(19).
Score: 0.204
-
Shim JH, Greenblatt MB, Zou W, Huang Z, Wein MN, Brady N, Hu D, Charron J, Brodkin HR, Petsko GA, Zaller D, Zhai B, Gygi S, Glimcher LH, Jones DC. Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts. J Clin Invest. 2013 Sep; 123(9):4010-22.
Score: 0.095